Garber Alan M is a director of Vertex Pharmaceuticals, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
EXELIXIS, INC.
25 Mar 24
144
EXELIXIS, INC.
21 Mar 24
4
EXELIXIS, INC.
2 Jun 23
4
VERTEX PHARMACEUTICALS INC / MA
3 May 23
4
EXELIXIS, INC.
23 Feb 23
4
EXELIXIS, INC.
27 May 22
4
VERTEX PHARMACEUTICALS INC / MA
3 May 22
4
EXELIXIS, INC.
3 Mar 22
4
EXELIXIS, INC.
28 May 21
4
VERTEX PHARMACEUTICALS INC / MA
4 May 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Mar 24 | EXEL Exelixis | Common Stock | Sell | Dispose S | No | Yes | 24.01 | 19,205 | 461.11 k | 35,703 |
21 Mar 24 | EXEL Exelixis | Common Stock | Option exercise | Acquire M | No | No | 19.57 | 23,491 | 459.72 k | 54,908 |
21 Mar 24 | EXEL Exelixis | Option Common Stock | Option exercise | Dispose M | No | No | 19.57 | 23,491 | 459.72 k | 0 |
1 Jun 23 | EXEL Exelixis | Option Common Stock | Grant | Acquire A | No | No | 19.39 | 44,087 | 854.85 k | 44,087 |
1 May 23 | VRTX Vertex Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 584 | 0.00 | 6,474 |
1 May 23 | VRTX Vertex Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 342.73 | 1,741 | 596.69 k | 1,741 |
21 Feb 23 | EXEL Exelixis | Common Stock | Sell | Dispose S | No | Yes | 17.49 | 40,000 | 699.60 k | 31,417 |
21 Feb 23 | EXEL Exelixis | Common Stock | Option exercise | Acquire M | No | No | 6.3 | 40,000 | 252.00 k | 71,417 |
21 Feb 23 | EXEL Exelixis | Option Common Stock | Option exercise | Dispose M | No | No | 6.3 | 40,000 | 252.00 k | 0 |